Dosage references
Dosage guides. Commonly cited research ranges for every compound in the catalog. Pick a compound from the index to open its full guide.
Semaglutide Metabolic 0.25 – 2.4 mg weekly Tirzepatide Metabolic 2.5 – 15 mg weekly Retatrutide Metabolic 1 – 12 mg weekly BPC-157 Recovery & repair 200 – 500 mcg per dose TB-500 Recovery & repair 2.5 – 5 mg weekly GHK-Cu Recovery & repair 1 – 2 mg daily CJC-1295 (DAC) + Ipamorelin GH axis 1 – 2 mg CJC (DAC) weekly + 200 – 300 mcg ipamorelin daily CJC-1295 (No DAC) GH axis 100 – 300 mcg per injection Ipamorelin GH axis 100 – 300 mcg per injection Tesamorelin GH axis 1 – 2 mg daily Epithalon Longevity & mitochondria 5 – 10 mg daily MOTS-c Longevity & mitochondria 5 – 10 mg per injection NAD+ Longevity & mitochondria 100 – 500 mg per session (IV protocols: 500 – 1000 mg) PT-141 (Bremelanotide) Neuropeptides 0.5 – 2 mg as needed Melanotan I Neuropeptides 250 – 500 mcg loading · 0.25 – 0.5 mg maintenance Melanotan II Neuropeptides 250 – 500 mcg loading · 0.5 – 1 mg maintenance SS-31 (Elamipretide) Longevity & mitochondria 1 – 10 mg per injection Kisspeptin-10 Neuropeptides 100 – 500 mcg per injection (or 6 – 10 mcg/kg) Selank Nootropics 250 – 500 mcg per dose (up to ~900 mcg daily split) Semax Nootropics 200 – 600 mcg per dose Oxytocin Neuropeptides 50 – 500 mcg per injection (intranasal: 24 – 40 IU) DSIP Neuropeptides 100 – 500 mcg per injection Thymosin Alpha-1 Immune 1.6 mg per dose (range 0.8 – 6.4 mg) KPV Immune 200 – 500 mcg daily BPC-157 + TB-500 Blend Blends BPC 250 – 500 mcg daily + TB-500 2.5 mg 1–2× weekly GLOW Stack Blends ≈ 2.3 – 2.5 mg total blend daily KLOW Blends ≈ 2 – 2.5 mg total blend daily GLP-1 receptor agonist. Glucose-dependent insulin secretion, slowed gastric emptying, and appetite regulation.
Common research dose 0.25 – 2.4 mg weekly
Frequency Once weekly, subcutaneous
Cycle Titrate in 4-week steps: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg. Ongoing once at target. Administer on an empty stomach. 2.4 mg is the clinical max (Wegovy); the 0.25–1.0 mg window is the most commonly cited research range.
Sources: FDA label · STEP trials Figures are commonly cited research ranges for protocol drafting only - not dosing advice, and never a recommendation for human or animal use. Always verify against the primary literature and the certificate for your specific lot.
